Additional Life Sciences Investment Opportunity

Life science startups satisfying the following criteria  may be eligible for an investment of up to $200,000 towards product development, if :

  • The company has successfully executed on initial seed funding through TEDCO or the SBIR/STTR programs or equivalent, and;
  • The company is developing a product (i) that requires FDA approval through the New Drug Application (NDA) or Biologic License Application (BLA) pathway, e.g., drugs, vaccines, biologics, etc.,
    that is defined by the FDA as a Class II or Class III medical device requiring approval through the 510(k) or Pre-Market Approval (PMA) pathways, e.g., medical devices, diagnostics, etc., and
  • The company has engaged with the FDA or regulatory consultants to determine the strategic pathway to approval, and;
  • The company can provide a 50% cash match towards the execution of product development milestones.